February 2019

Alignvest Acquisition II Corporation Announces Filing of Final Non-Offering Prospectus and Redemption Deadline – GlobeNewswire

Alignvest Acquisition II Corporation Announces Filing of Final Non-Offering Prospectus and Redemption Deadline GlobeNewswire TORONTO, Feb. 07, 2019 (GLOBE NEWSWIRE) — Alignvest Acquisition II Corporation (TSX: AQY.A, AQY.WT) (“AQY” or “Alignvest”) announces that it has filed …

Alignvest Acquisition II Corporation Announces Filing of Final Non-Offering Prospectus and Redemption Deadline – GlobeNewswire Read More »

Organovo Affirms Key Clinical Development Goals; Company Reports Fiscal Third-Quarter 2019 Results – Nasdaq

Organovo Affirms Key Clinical Development Goals; Company Reports Fiscal Third-Quarter 2019 Results Nasdaq Pre-Investigational New Drug meeting with the FDA expected to be held in calendar 2019 Submit first IND in calendar 2020. SAN DIEGO, Feb. 07, 2019–.

Organovo Affirms Key Clinical Development Goals; Company Reports Fiscal Third-Quarter 2019 Results – Nasdaq Read More »